Kelun-Biotech
Clinical and commercial-stage biotechnology company focused on antibody-drug conjugates and other oncology therapies.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Triple Negative Breast Cancer
Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast CancerPhase 3 · Recruiting · Metastatic Breast Cancer
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine TherapyPhase 3 · Recruiting · Metastatic Breast Cancer
A Study of SKB315 in Patients With Advanced Solid TumorsPhase 1 · Recruiting · Advanced Solid Tumors
A Study of SKB518 in Patients With Advanced Solid TumorsPhase 1 · Recruiting · Advanced Solid Tumors
SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.Phase 2 · Recruiting · Non-small Cell Lung Cancer
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/kelun-biotech/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.